Both in Pharmaceuticals
Geron vs Obsidian Therapeutics
Over the past year GERN returned −23.3% and OBX returned −36.5%; their daily moves had a correlation of -0.21.
GERN −23.3% OBX −36.5%Growth of $1, one year, split-adjusted
| Metric | GERN | OBX |
|---|---|---|
| Price | $1.04 | $11.30 |
| Market cap | $665.0M | $698.0M |
| Today | +11.29% | −14.59% |
| 1 month | −14.5% | −14.5% |
| 6 months | −34.5% | — |
| Year to date | −21.6% | — |
| 1 year | −13.8% | — |
| Revenue growth (YoY) | +17.2% | — |
| Gross margin | 83.9% | — |
| Net margin | −29.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $51.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 60.7% | — |
| Short % of float | 11.9% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).